Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00120328
Status:
TERMINATED
Last Update Posted:
2007-10-05
First Post:
2005-06-30
Brief Title:
To Determine the Effects of Avosentan on Doubling of Serum Creatinine End Stage Renal Disease and Death in Diabetic Nephropathy
Sponsor:
Speedel Pharma Ltd
Organization:
Speedel Pharma Ltd